Related Experiment Videos

Antitumor activity of acidic mannan fraction from bakers' yeast

Insights

This study demonstrates that bakers' yeast mannan (WAM025) exhibits significant antitumor properties. WAM025 administration led to complete survival in mice with specific ascites tumors, suggesting a potent immune-activating effect.

Area of Science:

  • Immunology
  • Biochemistry
  • Oncology

Background:

  • Yeast mannans are complex polysaccharides with diverse biological activities.
  • Antitumor properties of polysaccharides are often linked to immune system modulation.

Purpose of the Study:

  • To investigate the antitumor activity of an acidic fraction of bakers' yeast mannan (WAM025).
  • To explore the mechanism underlying the observed antitumor effects.

Main Methods:

  • An acidic yeast mannan fraction (WAM025) was isolated and characterized.
  • In vivo antitumor activity was assessed using Ehrlich, sarcoma 180, and Meth A ascites tumor models in mice.
  • Peritoneal adherent cells were analyzed for lysosomal enzyme levels and active oxygen generation.

Main Results:

  • WAM025 demonstrated marked antitumor activity against ascites tumors.
  • 100% survival was achieved in mice with Ehrlich or sarcoma 180 tumors following WAM025 treatment.
  • WAM025 administration significantly increased lysosomal enzyme levels and active oxygen generation in peritoneal adherent cells.

Conclusions:

  • Bakers' yeast mannan (WAM025) possesses significant in vivo antitumor activity.
  • The antitumor effect is likely mediated by the activation of peritoneal adherent cells, enhancing innate immune responses.

Related Concept Videos